GGrantIndex
Sort

78,016 grants matching breast cancer

Two Compartment Models to Improve Brain Tumor Therapy

$494,277
Edward A Neuwelt · Oregon Health & Science University · R01 · FY2008 · CA

Medicare Annual Wellness Visit Practice Redesign Toolkit: A Tailored Intervention to Improve Preventive Health Service Use

$494,272
Derjung M Tarn · University Of California Los Angeles · R33 · FY2023 · AG

RADIOPHARMACY AND ASSAYS

$494,263
David Morris Colcher · Beckman Research Institute/City Of Hope · P01 · FY2009 · CA

Predictors of Adult Leukemia

$494,244
Julie Ann Ross · University Of Minnesota · R01 · FY2008 · CA

Health Insurance, Labor Supply, and Health

$494,226
Cathy J. Bradley · Virginia Commonwealth University · R01 · FY2010 · CA

MCG Minority-Based Community Clinical Oncology Program

$494,205
Anand P Jillella · Augusta University · U10 · FY2011 · CA

Manipulating b1 integrin to enhance radiation therapy for breast cancer

$494,183
Catherine C Park · University Of Calif-Lawrenc Berkeley Lab · R01 · FY2009 · CA

The Development of Thermally-activated Metalloenediynes for Cancer Therapy

$494,172
Joseph R Dynlacht · Indiana University Indianapolis · R01 · FY2018 · CA

Hybrid Plasma Markers that Complement CT Imaging for Early Lung Cancer Detection

$494,170
Paul D Lampe · Fred Hutchinson Cancer Research Center · U01 · FY2016 · CA

Unraveling the Impact of Extracellular Vesicle-Loaded FXR1 mRNA on Re-educating Cancer Microenvironment

$494,160
Pradeep Chaluvally-Raghavan · Medical College Of Wisconsin · R01 · FY2025 · CA

Whole Genome Sequencing to Discover Familial Myeloma Risk Genes

$494,158
Steven Monroe Lipkin · Weill Medical Coll Of Cornell Univ · R01 · FY2016 · CA

Accountability for Cancer Care through Undoing Racism and Equity (ACCURE)

$494,151
Eugenia Eng · Univ Of North Carolina Chapel Hill · R01 · FY2015 · CA

Sustained regulation of hypothalamus-pituitary-ovary hormones with tissue-engineered ovarian constructs as a treatment for osteoporosis in females

$494,133
Justin Saul · Miami University Oxford · R01 · FY2024 · AR

Definition of Immune Infiltrate Phenotype and DNA Damage Response Deficits Across Diverse Murine Mammary Carcinomas

$494,120
Mary Helen Barcellos-Hoff · University Of California, San Francisco · R01 · FY2022 · CA

Breast Cancer Intravoxel-incoherent-motion MRI Multisite (BRIMM) Study - Resubmission - 1

$494,118
Eric Edward Sigmund · New York University School Of Medicine · UH3 · FY2024 · CA

A New Rapid DNA Platform for Neonatal Sepsis Diagnostics

$494,099
Dalibor Hodko · Nexogen, Inc. · R44 · FY2018 · HD

Breast cancer aggressiveness in young patients

$494,083
Patricia Schriver Steeg · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

Induced Differentiation to Deplete CSCs from Breast Cancer

$494,081
Robert A Weinberg · Whitehead Institute For Biomedical Res · R01 · FY2016 · CA

Induced Differentiation to Deplete CSCs from Breast Cancer

$494,081
Robert A Weinberg · Whitehead Institute For Biomedical Res · R01 · FY2014 · CA

Induced Differentiation to Deplete CSCs from Breast Cancer

$494,081
Robert A Weinberg · Whitehead Institute For Biomedical Res · R01 · FY2015 · CA

Induced Differentiation to Deplete CSCs from Breast Cancer

$494,081
Robert A Weinberg · Whitehead Institute For Biomedical Res · R01 · FY2017 · CA

Photochemical synthesis of bioactive molecules

$494,071
Corey Stephenson · University Of Michigan At Ann Arbor · R01 · FY2019 · GM

Pragmatic randomized trial of polygenic risk scoring for common diseases in primary care

$494,035
Jason L Vassy · Boston Va Research Institute, Inc. · R35 · FY2023 · HG

Administrative Core

$494,030
Charles A O'Brien · Univ Of Arkansas For Med Scis · P20 · FY2020 · GM

Regulation of Fibroblast Phenotype in Lung Fibrosis

$493,995
James S Hagood · University Of California, San Diego · R01 · FY2016 · HL